On Dec. 2, the Drug Enforcement Administration (DEA) will hold a hearing on the proposed rescheduling of marijuana from schedule I to schedule III of the Controlled Substances Act (CSA). The hearing is based on the Department of Health and Human Services view that marijuana has accepted medical use and less potential for abuse than some other medications on schedules I and II.
If marijuana is moved to schedule lll, the regulatory controls for that schedule of controlled substances will apply and its manufacture, distribution, dispensing and possession would remain subject to the CSA’s criminal prohibitions.
We are following this hearing and any subsequent legislation closely. Contact us with any questions you may have as this hearing progresses.